clinical 2,865 words KG: Psilocybin for Depression in MCI/AD (NCT04123314)
Contents

Psilocybin for Depression in MCI/AD (NCT04123314)

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (6)

Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.79
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.73
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.71
Trans-Synaptic Adhesion Molecule Modulation
Score: 0.54
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.48

Related Analyses (1)

What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed

Related Experiments (9)

Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.51
Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
TLR expression analysis in Parkinson's disease patients
clinical · proposed · Score: 0.85
TLR4 Activation Assay with NETs and Anti-CarP Antibodies
exploratory · proposed · Score: 0.85

Knowledge Graph (2 edges)

Psilocybin for Depression in MCI/AD (NCT04123314) references BDNF
Psilocybin for Depression in MCI/AD (NCT04123314) references TLR4

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.